Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

CRH Medical Corporation T.CRH

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies

CRH Medical Corp provides physicians with products for the treatment of gastrointestinal diseases. Its product is a single use, disposable, hemorrhoid technology used in treating hemorrhoid grades I - IV.
Price: $3.46 | Change: $-0.06 | %Change: -1.70%
Volume: 346,025 | Day High/Low: 3.57/3.45 | 52 Week High/Low: 4.37/0.61
View modes: 
0 stars

RE:Bloom Burton Conference

Anyone lucky enough to be at the conference, kindly share latest info..Thanks!!!  rate and reply
5 stars

Beacon Securities Commentary (6.00 TP)

CRH Medical Corporation (CRH-T) Record Quarterly Results   CRH reported record quarterly results with $9.6 million in revenue and $5.1 million in EBITDAS (53%) versus $2.0/$0.7 million (37...read more
0 stars

Bloom Burton Conference

CRH presented at 10:30 this morning. GLTA  rate and reply
0 stars

Q1 Seasonality

HOUSTON, TX--(Marketwired - April 09, 2015) - Nobilis Health Corp. (TSX: NHC) announces, on a consolidated basis, that its estimated revenue for the three months ending March 31, 2015 is between $33...read more
1 star

Analyst Comment

Last stock in the clip; a very fast comment. GLTA http://www.bnn.ca/Video/player.aspx?vid=605002 2015-05-01 BUY on WEAKNESS Bruce Campbell (1) (Market Call Minute.) A growth by acquisition...read more
0 stars

the state of biotech in Canada

http://www.bloomburton.com/brian-bloom-speaks-to-bnn-about-the-state-of-biotech-in-canada/  rate and reply
0 stars

RE:RE:Clarus Ups Target to 5.50

1.15-1.25 fx. fairly immaterial imo. If we go to parity, another story.  At 3.50, we're cheap regardless. Too cheap. Especially when you benchmark us against CXV, PHM, CXR, GUD, etc.  rate and reply
0 stars

RE:Clarus Ups Target to 5.50

I had highlighted the beat of Clarus`s EBITDA estimate in a post. The only thing wrong with their report is that oil and the Canadian dollar hve broken out to the upside. They assume $1.25 and now it...read more
0 stars

Clarus Ups Target to 5.50

Q1/15 Results - EBITDA Beats Our Estimate CRH Medical Corp. reported Q1/15 results on April 29th. The quarter ended March 31st, 2015 was the first full quarter CRH has booked revenues from...read more
0 stars

RE:RE:RE:Expectations

i apologize - revenue did come in a tad light. I see that now. I think you're right. with the stock up 80% ytd and most guys long at 60 some odd cents, there's always someone sitting on a huge gain...read more
5 stars

RE:RE:It makes sense

The company has stated many times that they intend through aquisition to become the premier anethstegioligist??? company in the US. We will not hear about a potential aquisition before it happens...read more
0 stars

RE:RE:It makes sense

The data I research is from TD which shows revenue growth is below expectation and we should not use Q1 2014 to compare (that is what the company uses and not the market). The way for margin...read more
0 stars

RE:RE:Expectations

I am not 100% sure if that is it either Styless.  But some future M&A guidance would be helpful.  Also the isn't enough following with this name either. But next week they are presenting at Canada's...read more
0 stars

RE:It makes sense

i have to disagree. i think CRH beat on most estimates if not all. Not sure what you're referencing as a base comparison for revenues/expenses.  The company even suggested margins can improve in the...read more
0 stars

It makes sense

I long this stock and did not sell a single share but I was too disappointed with the company. First the operating cost exceeds e pectation and the revenue fall short of expectation ( it is not good...read more
0 stars

RE:Expectations

I dont know if that's it. i just think there isn't enouhg of a following with this name.  After a 3.40 financing just weeks ago, who's the next marginal buyer. need to get retail more up to speed...read more
0 stars

RE:Expectations

For details on the link click agenda  rate and reply
0 stars

Expectations

I think retail investors were disappointed that there was no new update on further takeover plans. At 10:30 Monday May 4th CRH Medical is presenting at the healthcare investor conference.   I expect...read more
0 stars

RE:RE:RE:RE:RE:Did I Miss Something

Considering Q1 2015 results, this whole business sector, the companie's financial position, what's more to come, selling CRH shares at this 3.50$ valuation simply goes against common sense.  rate and reply
0 stars

RE:RE:RE:RE:Did I Miss Something

This is one of the best companies in this sector, solid revenue with good organic growth and once a few more aquisitions take place the market will take notice, just takes time.  rate and reply